Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?

View/ Open
Author
Note: Order does not necessarily reflect citation order of authors.Published Version
https://doi.org/10.4061/2011/973245Metadata
Show full item recordCitation
Westover, Kenneth D., M. Brandon Westover, Eric P. Winer, Andrea L. Richardson, J. Dirk Iglehart, and Rinaa S. Punglia. 2011. Should a sentinel node biopsy be performed in patients with high-risk breast cancer?. International Journal of Breast Cancer 973245.Abstract
A negative sentinel lymph node (SLN) biopsy spares many breast cancer patients the complications associated with lymph node irradiation or additional surgery. However, patients at high risk for nodal involvement based on clinical characteristics may remain at unacceptably high risk of axillary disease even after a negative SLN biopsy result. A Bayesian nomogram was designed to combine the probability of axillary disease prior to nodal biopsy with customized test characteristics for an SLN biopsy and provides the probability of axillary disease despite a negative SLN biopsy. Users may individualize the sensitivity of an SLN biopsy based on factors known to modify the sensitivity of the procedure. This tool may be useful in identifying patients who should have expanded upfront exploration of the axilla or comprehensive axillary irradiation.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262582/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8704123
Collections
- HMS Scholarly Articles [17842]
Contact administrator regarding this item (to report mistakes or request changes)